KUALA LUMPUR, April 30 -- As one of the world’s leading innovators in skin science research for nearly six decades, Mary Kay Inc continues its longstanding commitment to the advancement of cutting-edge skin care at the 2021 Reunión Anual de Dermatólogos Latinoamericanos (RADLA), a scientific Latin American conference.
The four-day virtual event beginning April 15 has provided an opportunity for dermatology experts worldwide to exchange information on technological advances and new scientific achievements.
Through live and on-demand sessions, the event gathered researchers, academicians and scientists from the global dermatology community.
Scientific posters and sessions unveiled the latest in skin science research and analysis
Mary Kay was proud to share research on a gradual retinisation process that significantly improves tolerance to higher concentrated pure retinol, while still delivering retinol’s key skin benefits.
According to a statement, this gradual retinisation process was developed using a series of 12-week safety and clinical studies.
“Through safety and clinical studies in both the United States and China, we found that a gradual retinisation process can significantly improve tolerability and still provide known skin benefits associated with retinol,” said Mary Kay Inc Chief Scientific Officer, Dr Lucy Gildea.
“We are honoured to present our findings at RADLA among the world’s foremost skin care experts at this prestigious event.
“Our participation in RADLA is a tremendous opportunity to collaborate as we continue our commitment to remain at the forefront of advancements in skin health.
“It’s one of a series of partnerships with the scientific and academic communities to further expand Mary Kay’s leadership in science-based product development as we continue to provide the highest quality products to our Mary Kay Independent Beauty Consultants and brand lovers worldwide.”
-- BERNAMA
Comments